Fig. 6.

Fig. 6. Non-toxic effect of SGBP on various organs and the immune system. All markers have been measured in C57BL/6 mice treated with SGBP 50 mg/kg or 100 mg/kg oral administration for 1 week or 4 weeks. (A-D) Analysis of organdamage markers in the blood of SGBP-treated mice. The markers include ALT, AST, BUN, and creatinine (n = 10). (E, F) Analysis of immune-activation markers in the blood of SGBP-treated mice. (G) Analysis of albumin levels of SGBP-treated mice. Data are presented as the mean ± standard deviation (SD); *p < 0.05, **p < 0.01, ***p < 0.001, and ***p < 0.0001 (t-test, all experiments were biologically independent). Statistically non-significant results are not indicated in the figure.

© J. Microbiol. Biotechnol.